Xstelos Corp.'s Net Worth
$204 Thousand
Who is Xstelos Corp.?
Xstelos Corp. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS, INC., and Myrexis, Inc..
SEC CIK
Xstelos Corp.'s CIK is 0001571659
Past Insider Trading and Trends
2018 was Xstelos Corp.'s most active year for acquiring shares with 45 total transactions. Xstelos Corp.'s most active month to acquire stocks was the month of June. 2020 was Xstelos Corp.'s most active year for disposing of shares, totalling 2 transactions. Xstelos Corp.'s most active month to dispose stocks was the month of July. 2020 saw Xstelos Corp. paying a total of $283,823.76 for 1,811,738 shares, this is the most they've acquired in one year. In 2021 Xstelos Corp. cashed out on 107,500 shares for a total of $41,903.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENZON PHARMACEUTICALS, INC. (ENZN) Snapshot price: $0.1
InvestorXstelos Corp. owns 9,334,148 units of Common Stock, $0.01 par value which is worth $933,414.80. From 2018 to 2021 Xstelos Corp. acquired a total of 3,811,763 shares in ENZON PHARMACEUTICALS, INC. at a cost of $785,366.29, Xstelos also disposed a total of 184,600 shares of ENZON PHARMACEUTICALS, INC. equalling to $56,241.14.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.30% | -107.50K |
$0.39 | -$41,903.50 | 2.39M |
Aug 13
| |||
Form 4
| -4.62% | -77.10K |
$0.19 | -$14,337.64 | 1.59M |
Aug 24 - Aug 25
| |||
Form 4
| +31.76% | 506.29K |
$0.20 | $101,258.40 | 2.1M |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
| +41.45% | 652.72K |
$0.14 | $91,282.68 | 2.23M |
Mar 13 - Mar 26
| |||
Form 4
| +41.45% | 652.72K |
$0.14 | $91,282.68 | 2.23M |
Mar 13 - Mar 26
| |||
Form 4
| +0.82% | 51K |
$0.25 | $12,750.00 | 6.29M |
Feb 11
| |||
Form 4
| +17.97% | 950.62K |
$0.25 | $230,186.61 | 6.24M |
Aug 15 - Jan 7
| |||
Form 4
| +27.91% | 1M |
$0.26 | $258,605.91 | 4.58M |
Apr 13 - Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Myrexis, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |